Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)
Clinical trial NCT06940141 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06940141
- Sponsor
- Connect Biopharm LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-08
- Primary completion
- 2026-07-17
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.